The ASX Leader in #CellTherapy #CLTXCART #Chlorotoxin #NKCells $CHM
Australia
Joined September 2020
- Tweets664
- Following482
- Followers1.3K
- Likes1.4K
Chimeric Therapeutics ASX: CHM retweeted
Chimeric Therapeutics (ASX:CHM) appoints Dr McQualter as CEO amid advancing cancer trials
@Chimeric #appointment #ASX $CHM
kalkinemedia.com/au/news/fea…
Chimeric Therapeutics ASX: CHM retweeted
WRAP 🗞️ @Lotus_Resources accelerates Kayelekera uranium restart; @Chimeric achieves positive response in leukaemia trial; @KaliMetals surges on expanded deal with SQM
📰 Read here: bit.ly/3Y0ns3a
Stocks in focus 🔎 #E25 $WAF $LOT $AGE #KM1 $LRV $FHE #PV1
Chimeric Therapeutics ASX: CHM retweeted
Chimeric Therapeutics (ASX:CHM) Reports Success in Phase 1b Clinical Trial for Advanced Cancers
@Chimeric #clinicaltrial #ASX $CHM
kalkinemedia.com/au/news/fea…
Chimeric Therapeutics ASX: CHM retweeted
Chimeric's (ASX:CHM) Cancer Cell Therapy Trial Opens for Patient Enrolment at University of Pennsylvania
@Chimeric #celltherapy #ASX $CHM
kalkinemedia.com/au/news/fea…
Chimeric Therapeutics ASX: CHM retweeted
Chimeric Therapeutics (ASX:CHM) and Cell Therapies Collaborate for Local Production of CAR T Therapies
@Chimeric #collaboration #celltherapy #ASX $CHM
kalkinemedia.com/au/news/fea…
Chimeric Therapeutics ASX: CHM retweeted
. @Chimeric (ASX: CHM) is advancing three platform technologies through multiple phase 1A and phase 1B clinical trials.
#CyberSecurity #SmallBusinessSupport #TechSafety #DigitalProtection #CyberCrime #BankingSecurity #TelcoSupport #CyberDefense
youtu.be/b4JegQiOPVU?utm_sou…
Chimeric Therapeutics ASX: CHM retweeted
Cancer cell therapy trial enrolment sparks 15.79% surge in Chimeric Therapeutics (ASX: CHM) shares
@Chimeric #cell therapy #ASX $CHM
kalkinemedia.com/au/news/fea…
Chimeric Therapeutics ASX: CHM retweeted
We spoke to Dr Rebecca McQualter, COO of @Chimeric Therapeutics (ASX: $CHM) 🧬💉🧫 about the three exciting programmes in CAR-T and NK cells, and the favourable clinical data that has been gathered in a range of cancers 👍 😃
#ASX #chimerictherapeutics
stocksdownunder.com/video/ch…
Chimeric Therapeutics ASX: CHM retweeted
Chimeric Therapeutics (#ASX: $CHM) begins innovative therapy trial for acute myeloid leukaemia
smallcaps.com.au/chimeric-th… @Chimeric
Chimeric Therapeutics ASX: CHM retweeted
My contribution to Stockhead with some stocks to watch @MaronanMetals $MMA Saturn Metals $STN Aurumin $AUN #1AD @AdAlta1AD $CHM @Chimeric Radiopharm $RAD @TeamRadioPharm
stockhead.com.au/experts/mon…
Chimeric Therapeutics ASX: CHM retweeted
Chimeric Therapeutics (#ASX: $CHM) reports positive in vitro data for CHM 1301 on pancreatic and ovarian cancers
smallcaps.com.au/chimeric-th… @Chimeric
Chimeric Therapeutics ASX: CHM retweeted
Biotechnology company @Chimeric expects a phase-1B #clinicaltrial into its “natural killer” #celltherapy for newly-diagnosed patients with acute myeloid #leukemia to be open for new enrolments before the end of the year.
$CHM #BULLSNBEARSWA #ASX
businessnews.com.au/article/…
Chimeric Therapeutics ASX: CHM retweeted
#Medtech @Chimeric says it is closer to unlocking treatment hope for patients suffering from the deadliest form of brain #cancer after dosing its first patient as part of a phase-1B trial.
$CHM #ChimericTherapeutics #BULLSNBEARSWA @wabusinessnews #ASX businessnews.com.au/article/…
Chimeric Therapeutics ASX: CHM retweeted
The USFDA has provided crucial investigational new drug clearance for clinical-stage cell therapy company @Chimeric to begin trials using its “CHM 2101" gastrointestinal #cancer therapy.
$CHM #ChimericTherapeutics #BULLSNBEARSWA @wabusinessnews #ASX businessnews.com.au/article/…
Chimeric Therapeutics ASX: CHM retweeted
Friday's webinar will provide a keynote presentation from Perennial Partners & discuss mining tech, industrial minerals & cell therapy. Register now bit.ly/HGW_27_10 to hear from @perennial_value @ImdexLimited $IMD @HeavyMinerals $HVY @Chimeric $CHM
Chimeric Therapeutics ASX: CHM retweeted
@NadineBlayney spoke to @Chimeric's MD Jennifer Chow about the positive interim data from a clinical trial for late stage brain cancer treatment.
The $CHM trial showed promising results, with 55% of patients achieving disease control and extended survival rates, including cases of 19 and 14+ months.
✨Watch the full interview here: bit.ly/472I6T4
#ausbiz #braincancer #Glioblastoma
Chimeric Therapeutics ASX: CHM retweeted
Chimeric Therapeutics (#ASX: $CHM) reports positive interim data from CLTX CAR T brain cancer trial
smallcaps.com.au/chimeric-th… @Chimeric
Chimeric Therapeutics ASX: CHM retweeted
Chimeric Therapeutics (ASX: CHM) announces CHM 0201 clinical study agreement for acute myeloid leukaemia
@Chimeric #clinicalstudy #ASX $CHM
kalkinemedia.com/au/news/fea…
Chimeric Therapeutics ASX: CHM retweeted
Chimeric Therapeutics (#ASX: $CHM) completes further dosing in brain cancer clinical trial
smallcaps.com.au/chimeric-th… @Chimeric